Repository logo
 

Metabolic markers of MRI-confirmed lacunar stroke: observational and Mendelian randomization analyses

Accepted version
Peer-reviewed

Change log

Abstract

Background and Objectives: Lacunar stroke results from cerebral small vessel disease (SVD) and is a major cause of vascular dementia and cognitive decline. We aimed to evaluate the associations of metabolites with lacunar stroke, neuroimaging markers of SVD, and cognition to help elucidate SVD pathogenesis.

Methods: In a clinical cohort of MRI-confirmed lacunar stroke cases and unrelated hospital controls recruited from stroke centers across the UK, we assayed 250 serum metabolites using NMR spectroscopy. We investigated the association of metabolites with MRI-confirmed lacunar stroke, neuroimaging markers, and cognitive impairment. We also conducted a genome-wide association analysis for each metabolite and applied bidirectional Mendelian randomization (MR) to investigate causality.

Results: Among 2,408 participants, there were 1,456 lacunar stroke cases (mean age, 62 [SD 12]; 34% female) and 952 controls (mean age, 57 [SD 6]; 38% female). Observational analyses identified 211 metabolites that were significantly associated with lacunar stroke. MR analyses identified significant evidence to support causal associations of two of these metabolites, glycine and the proportion of cholesterol to total lipids within medium LDL (%C/Total in M-LDL), with two distinct lacunar stroke subtypes—isolated lacunar infarcts (ILI, 1 lacunar infarct with Fazekas grade <2) and multiple lacunar infarcts and/or leukoaraiosis (MLI/LA, >1 lacunar infarct and/or Fazekas grade ≥2). Glycine was inversely associated with ILI (OR: 0.704, 95% CI 0.585-0.848), and %C/Total in M-LDL was inversely associated with MLI/LA (OR: 0.541, 95% CI 0.401-0.730). Five metabolites (Total S-HDL, S-HDL concentration, PL in S-HDL, %CE/Total in L-LDL, and lactate) were significantly associated with executive functioning and processing speed in observational analyses. MR analyses also implicated genetically determined levels of ω-3/Total FA with two diffusion tensor imaging markers of SVD. Overall, the most robust and consistent associations across both observational and MR analyses were identified for glycine and %C/Total in M-LDL with lacunar stroke subtypes.

Discussion: We identified inverse associations of glycine and the proportion of cholesterol to total lipids within medium LDL with distinct subtypes of MRI-confirmed lacunar stroke. These findings reveal metabolomics signatures associated with lacunar stroke subtypes, which may inform future studies of SVD pathogenesis and biomarker development.

Description

Journal Title

Neurology

Conference Name

Journal ISSN

0028-3878
1526-632X

Volume Title

Publisher

Lippincott, Williams & Wilkins

Publisher DOI

Publisher URL

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
British Heart Foundation (RG/F/22/110052)
British Heart Foundation (RE/18/1/34212)
British Heart Foundation (RE/24/130011)
Cambridge University Hospitals NHS Foundation Trust (CUH) (Unknown)
Cambridge University Hospitals NHS Foundation Trust (CUH) (BRC4 Y1)
Stroke Association (TSA BHF 2010/01)
Stroke Association (TSA 2013/01)
Alzheimer's Society (573 (AS-RF-21-017))
British Heart Foundation (RG/16/4/32218)
National Institute for Health and Care Research (IS-BRC-1215-20014)
This research was supported by the British Heart Foundation (RG/F/22/110052). Infrastructural support was provided by the Cambridge British Heart Foundation Centre of Research Excellence (RE/18/1/34212; RE/24/130011) and the Cambridge University Hospitals National Institute for Health and Care Research (NIHR) Biomedical Research Centre (NIHR203312). ELH was supported by the Alzheimer’s Society (AS-RF-21-017). Collection of the UK Young Lacunar Stroke DNA Study (DNA Lacunar 1) was primarily supported by the Wellcome Trust (WT072952) with additional support from the Stroke Association (TSA 2010/01). Genotyping of the DNA Lacunar 1 samples was supported by a Stroke Association grant (TSA 2013/01). Collection and genotyping of the UK Young Lacunar Stroke DNA Study 2 (DNA Lacunar 2) was supported by British Heart Foundation Programme Grants (RG/16/4/32218; RG/F/22/110052). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.